• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组人脂皮质蛋白I对大鼠胶质瘤模型脑水肿的影响。

Effect of recombinant human lipocortin I on brain oedema in a rat glioma model.

作者信息

Chang C C, Shinonaga M, Kuwabara T, Mima T, Shigeno T

机构信息

Yokohama City University, Japan.

出版信息

Acta Neurochir Suppl (Wien). 1990;51:145-7. doi: 10.1007/978-3-7091-9115-6_49.

DOI:10.1007/978-3-7091-9115-6_49
PMID:2151008
Abstract

Glucocorticoids have been extensively used to treat brain oedema, but little is known on the mechanisms of steroids in the prevention and resolution of tumour-induced brain oedema. Recently, the mechanism of steroid action is thought to involve synthesis of proteins with antiphospholipase activity called lipocortins. In a previous study, we have demonstrated the efficacy of dexamethasone (DEX) in resolving peritumoural oedema in a rat glioma model. Using the same model, we studied the effect of recombinant human lipocortin I on the resolution of peritumoural oedema. Intracerebral tumours were produced in 6-week-old Wistar rats by implantation of rat glioma C6 cells. In comparison with sham-operated controls, the tumour-implanted animals showed significant increase in the cortical water content, which was reduced by DEX administration to the level in the sham-operated controls. The water content within the tumour was also significantly decreased by DEX treatment. On the other hand, there was no difference in water content between lipocortin-treated and non-treated animals. These findings suggest that tumour-induced brain oedema can be reduced by DEX treatment but not by lipocortin. In conclusion, it is doubtful whether glucocorticoids exert their action in resolving brain oedema by inducing PLA2 inhibitory proteins named lipocortins.

摘要

糖皮质激素已被广泛用于治疗脑水肿,但对于类固醇预防和消退肿瘤诱导的脑水肿的机制却知之甚少。最近,类固醇的作用机制被认为涉及合成具有抗磷脂酶活性的蛋白质,即脂皮质素。在之前的一项研究中,我们已经证明地塞米松(DEX)在大鼠胶质瘤模型中消退肿瘤周围水肿的有效性。使用相同的模型,我们研究了重组人脂皮质素I对肿瘤周围水肿消退的影响。通过植入大鼠胶质瘤C6细胞在6周龄的Wistar大鼠中产生脑内肿瘤。与假手术对照组相比,植入肿瘤的动物皮质含水量显著增加,通过给予DEX可将其降低至假手术对照组的水平。DEX治疗也显著降低了肿瘤内的含水量。另一方面,脂皮质素治疗组和未治疗组动物的含水量没有差异。这些发现表明,肿瘤诱导的脑水肿可通过DEX治疗而不是脂皮质素降低。总之,糖皮质激素是否通过诱导名为脂皮质素的PLA2抑制蛋白来发挥消退脑水肿的作用值得怀疑。

相似文献

1
Effect of recombinant human lipocortin I on brain oedema in a rat glioma model.重组人脂皮质蛋白I对大鼠胶质瘤模型脑水肿的影响。
Acta Neurochir Suppl (Wien). 1990;51:145-7. doi: 10.1007/978-3-7091-9115-6_49.
2
Neurotransmitter amines in brain edema of a rat glioma model.大鼠胶质瘤模型脑水肿中的神经递质胺类
Neurol Med Chir (Tokyo). 1989 Mar;29(3):187-91. doi: 10.2176/nmc.29.187.
3
Effect of dexamethasone on neurotransmitter amines in a rat glioma model.
Adv Neurol. 1990;52:483-9.
4
Oxygen free radicals in the genesis of peritumoural brain oedema in experimental malignant brain tumours.
Acta Neurochir Suppl (Wien). 1990;51:142-4. doi: 10.1007/978-3-7091-9115-6_48.
5
Effect of niravoline (RU51599), a kappa-opioid receptor agonist, on tumour-origin brain oedema.
Acta Neurochir (Wien). 1999;141(7):771-8. doi: 10.1007/s007010050374.
6
The effect of the aminosteroid U-78517G on peritumoural brain oedema.氨基甾体U-78517G对肿瘤周围脑水肿的影响。
Acta Neurochir Suppl (Wien). 1990;51:158-9. doi: 10.1007/978-3-7091-9115-6_53.
7
Formation and resolution of white matter oedema in various types of brain tumours.不同类型脑肿瘤中白质水肿的形成与消退
Acta Neurochir Suppl (Wien). 1990;51:149-51. doi: 10.1007/978-3-7091-9115-6_50.
8
Corticosteroid therapy of experimental tumour oedema.实验性肿瘤水肿的皮质类固醇治疗
Neurosurg Rev. 1981;4(4):185-90. doi: 10.1007/BF01743708.
9
Factors affecting the extension of peritumoural brain oedema. A CT-study.影响肿瘤周围脑肿胀扩展的因素。一项CT研究。
Acta Neurochir (Wien). 1988;95(1-2):19-24. doi: 10.1007/BF01793077.
10
Oedema formation in experimental photo-irradiation therapy of brain tumours using 5-ALA.
Acta Neurochir (Wien). 2005 Jan;147(1):57-65; discussion 65. doi: 10.1007/s00701-004-0422-1.